The heterogeneous manifestations of MYH9-related disorder (MYH9-RD), characterized by macrothrombocytopenia, Döhle-like inclusion bodies in leukocytes, bleeding of variable severity with, in some cases, ear, eye, kidney, and liver involvement, make the diagnosis for these patients still challenging in clinical practice. We collected phenotypic data and analyzed the genetic variants in more than 3,000 patients with a bleeding or platelet disorder. Patients were enrolled in the BRIDGE-BPD and ThromboGenomics Projects and their samples processed by high throughput sequencing (HTS). We identified 50 patients with a rare variant in MYH9. All patients had macrothrombocytes and all except two had thrombocytopenia. Some degree of bleeding diathesis was reported in 41 of the 50 patients. Eleven patients presented hearing impairment, three renal failure and two elevated liver enzymes. Among the 28 rare variants identified in MYH9, 12 were novel. HTS was instrumental in diagnosing 23 patients (46%). Our results confirm the clinical heterogeneity of MYH9-RD and show that, in the presence of an unclassified platelet disorder with macrothrombocytes, MYH9-RD should always be considered. A HTS-based strategy is a reliable method to reach a conclusive diagnosis of MYH9-RD in clinical practice.
Keywords: ACMG guidelines; MYH9-related disorders; clinical diagnosis; genomics; high throughput sequencing; variant classification.
© 2019 The Authors. Human Mutation published by Wiley Periodicals, Inc.
Diagnosis and treatment of MYH9-RD in an Australasian cohort with thrombocytopenia.Platelets. 2018 Dec;29(8):793-800. doi: 10.1080/09537104.2017.1356920. Epub 2017 Nov 1. Platelets. 2018. PMID: 29090586
A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature.Medicine (Baltimore). 2020 Jan;99(4):e18887. doi: 10.1097/MD.0000000000018887. Medicine (Baltimore). 2020. PMID: 31977897 Free PMC article.
MYH9-Related Disorders.2008 Nov 20 [updated 2015 Jul 16]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2020. GeneReviews®. 1993–2020. PMID: 20301740 Free Books & Documents. Review.
Successful renal transplantation in MYH9-related disorder with severe macrothrombocytopenia: first report in Korea.Transplant Proc. 2014;46(2):654-6. doi: 10.1016/j.transproceed.2013.11.144. Transplant Proc. 2014. PMID: 24656038
[Renal diseases related to MYH9 disorders].G Ital Nefrol. 2017 Apr;34(2):40-57. G Ital Nefrol. 2017. PMID: 28682562 Review. Italian.
- Althaus K., & Greinacher A. (2009). MYH9‐related platelet disorders. Seminars in Thrombosis and Hemostasis, 35, 189–203. - PubMed
- Arrondel C., Vodovar N., Knebelmann B., Grünfeld J. P., Gubler M. C., Antignac C., … Heidet L. (2002). Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. Journal of the American Society of Nephrology, 13, 65–74. - PubMed
- Balduini C. L., Cattaneo M., Fabris F., Gresele P., Iolascon A., Pulcinelli F. M., … Italian Gruppo di Studio delle P. (2003). Inherited thrombocytopenias: A proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica, 88, 582–592. - PubMed
- Balduini C. L., Pecci A., & Noris P. (2012). Inherited thrombocytopenias: The evolving spectrum. Hämostaseologie, 32, 259–270. - PubMed
- Balduini C. L., Pecci A., & Savoia A. (2011). Recent advances in the understanding and management of MYH9‐related inherited thrombocytopenias. British Journal of Haematology, 154, 161–174. - PubMed
- FIS-Fondos FEDER
- NIHR Imperial College Biomedical Research Centre
- RBAG/181/National Institute for Health Research
- RBAG/142/NHS Blood and Transplant
- MR/J011711/1/MRC_/Medical Research Council/United Kingdom
- 226/BHF_/British Heart Foundation/United Kingdom
- Fondazione Umberto Veronesi
- 208/BHF_/British Heart Foundation/United Kingdom
- NIHR BioResource - Rare Diseases
- RBAG/342/WT_/Wellcome Trust/United Kingdom
- RBAG/344/European Commission
- RBAG/245/BHF_/British Heart Foundation/United Kingdom
- Telethon Foundation Grant
- RG65966/National Institute for Health Research